The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1273-1280

  Zhu, Xiao ^a   Zhang, Jinfang ^b   Fan, Wenguo ^c,d   Wang, Fang ^e   Yao, Hong ^b,f   Wang, Zifeng ^e,g   Hou, Shengping ^h   Tian, Yinghong ⁱ   Fu, Weiming ^j   Xie, Dan ^e   Zhu, Wei ^a   Long, Jun ^c   Wu, Leijie ^c   Zheng, Xuebao ^a   Kung, Hsiangfu ^b,f   Zhou, Keyuan ^a   Lin, Marie C M ^g   Luo, Hui ^a   Li, Dongpei ^c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h CHONGQING MEDICAL UNIVERSITY   (China)

ⁱ SOUTHERN MEDICAL UNIVERSITY   (China)

^j INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 78;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE REGULATED PROTEIN 78 GENE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HEAT-SHOCK PROTEINS; HELA CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-2; RISK; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84878986352     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt061     Document Type: Article

References (43)

1. Yang,J.D. et al. (2010) Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol., 7, 448-458.
2. Zhou,Y.Z. et al. (1987) Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. J. Natl Cancer Inst., 79, 223-231.
3. Nakamoto,Y. et al. (1998) Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med., 188, 341-350.
4. Saigo,K. et al. (2008) Integration of hepatitis B virus DNA into the myeloid/ lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum. Mutat., 29, 703-708.
5. Yu,X.J. et al. (2011) dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum. Mutat., 32, E2308-E2316.
6. Haas,I.G. et al. (1983) Immunoglobulin heavy chain binding protein. Nature, 306, 387-389.
7. Rose,M.D. et al. (1989) KAR2, a karyogamy gene, is the yeast homolog of the mammalian BiP/GRP78 gene. Cell, 57, 1211-1221.
8. Liu,M. et al. (2010) The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J. Clin. Invest., 120, 1914-1924.
9. Flynn,G.C. et al. (1989) Peptide binding and release by proteins implicated as catalysts of protein assembly. Science, 245, 385-390.
10. Jiang,C.C. et al. (2009) Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. Carcinogenesis, 30, 197-204.
11. Gorbatyuk,M.S. et al. (2010) Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc. Natl Acad. Sci. U.S.A., 107, 5961-5966.
12. Dong,D. et al. (2011) A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res., 71, 2848-2857.
13. Arap,M.A. et al. (2004) Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell, 6, 275-284.
14. Su,R. et al. (2010) Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer, 10, 20.
15. Zhu,X. et al. (2009) Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis. Int. J. Cancer, 125, 1352-1357.
16. Ito,Y. et al. (2002) Linkage of elevated ets-2 expression to hepatocarcinogenesis. Anticancer Res., 22, 2385-2389.
17. Galang,C.K. et al. (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J. Biol. Chem., 279, 11281-11292.
18. Obata,H. et al. (1980) A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int. J. Cancer, 25, 741-747.
19. Blomley,M.J. et al. (2003) Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut, 52, 1188-1193.
20. Valls,C. et al. (1995) Preoperative TNM staging of hepatocellular carcinoma in hepatic transplantation: value of lipiodol computed tomography. Transplant. Proc., 27, 2309-2310.
21. Llovet,J.M. et al. (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis., 19, 329-338.
22. Katyal,S. et al. (2000) Extrahepatic metastases of hepatocellular carcinoma. Radiology, 216, 698-703.
23. Schwartz,S. et al. (2003) Human-mouse alignments with BLASTZ. Genome Res., 13, 103-107.
24. Siepel,A. et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res., 15, 1034-1050.
25. Rhead,B. et al. (2010) The UCSC Genome Browser database: update 2010. Nucleic Acids Res., 38, D613-D619.
26. Barrett,J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
27. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
28. Zhu,X. et al. (2009) Genetic polymorphisms and haplotype structures of HSPA5 gene in the Han population of Southern China. Tissue Antigens, 74, 420-423.
29. Kakiuchi,C. et al. (2005) Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochem. Biophys. Res. Commun., 336, 1136-1143.
30. Gal-Yam,E.N. et al. (2006) Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet., 2, e160.
31. De Val,S. et al. (2008) Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell, 135, 1053-1064.
32. Kodandapani,R. et al. (1996) A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature, 380, 456-460.
33. Seth,A. et al. (2005) ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer, 41, 2462-2478.
34. Al-azawi,D. et al. (2008) Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer. Oncogene, 27, 3021-3031.
35. Wang,M. et al. (2009) Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox Signal., 11, 2307-2316.
36. Pfaffenbach,K.T. et al. (2011) The critical role of GRP78 in physiologic and pathologic stress. Curr. Opin. Cell Biol., 23, 150-156.
37. Negrini,S. et al. (2010) Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol., 11, 220-228.
38. Little,M.P. (2010) Cancer models, genomic instability and somatic cellular Darwinian evolution. Biol. Direct, 5, 19; discussion 19.
39. Vineis,P. et al. (2010) Models of carcinogenesis: an overview. Carcinogenesis, 31, 1703-1709.
40. Malhi,H. et al. (2011) Endoplasmic reticulum stress in liver disease. J. Hepatol., 54, 795-809.
41. Hsu,W.C. et al. (2008) Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer's disease. J. Neural Transm., 115, 1537-1543.
42. Hu,C.C. et al. (2009) Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes. J. Exp. Med., 206, 2429-2440.
43. Horikawa,Y. et al. (2008) Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions. Curr. Opin. Urol., 18, 493-498.